North American Contraceptive Market size is predicted to reach USD 8.8 billion by 2028, according to a latest forecast report by Graphical Research.

The increasing prevalence of sexually transmitted diseases (STDs) and sexually transmitted infections (STIs) in the U.S. is expected to drive the regional market growth. According to the National Centers for Biotechnology Information (NCBI), in 2019, the incidence of sexually transmitted infections (STIs) is rising, especially in adolescents (aged 15–24 years). Despite accounting for only a quarter of the population, adolescents represent approximately half of STIs in the U.S. annually. Around 20 million new STIs are reported in the U.S. every year. Estimations state that 1 out of 4 sexually active adolescent females suffer from an STI, with Chlamydia trachomatis (CT) and human papillomavirus (HPV) being the most prevalent infection.

The increasing number of unintended pregnancies and the surged awareness regarding family planning techniques is anticipated to proliferate the North America contraceptive market demand. Unintended pregnancies comprise unwanted or mistimed pregnancies. For instance, as per the Healthy People 2020 statistics, approximately 45% of 6.1 million pregnancies in the U.S. every year are unwanted. These pregnancies are concerned with multiple negative health as well as financial consequences. The public spending related to unintended pregnancies are substantial and increases the economic burden on healthcare system. In order to reduce the occurrence of unintended pregnancies, the government authorities & public organizations are promoting implementation and adoption of family planning methods. The increased awareness and adoption of family planning is expected to drive the use of contraception in reducing pregnancy-related health concerns among women as well as infants. For instance, the Title X family planning program and Medicaid family planning services are funded by the government to promote the availability & accessibility for contraceptives among low-income women.

The drugs segment accounted for 55% market share in 2021, owing to the increasing use and demand for contraceptive drugs in the region. The birth control pill is the widely prescribed contraceptive drug in the U.S. For instance, according to the National Centers for Biotechnology Information (NCBI) article, in 2021, around 25% of women aged 15 to 44 years that currently practice contraception reported that oral contraceptive pills are their preferred method of choice. The most commonly used oral contraceptive pill is the hormonal pill with a combination of estrogen and progesterone.

Browse detailed statistical insights from the report, “North America Contraceptives Market Forecast 2028 By Product (Drugs {Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives}, Devices {Condoms [Male, Female], Diaphragms, Contraceptive Sponges, Vaginal Rings, Subdermal Implants, Intra-uterine Devices [Copper IUD, Hormonal IUD]}), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
https://www.graphicalresearch.com/industry-insights/2139/north-america-contraceptives-market

Canada contraceptive market will expand at 6% CAGR and exceed over USD 442 million by 2028, due to the rising prevalence of sexually transmitted diseases (STDs) & sexually transmitted infections (STIs) and adoption of supportive initiatives offering access to contraceptives & family planning services. For instance, as per the Government of Canada statistics, in 2018, the prevalence rates of STIs have been rising incrementally. In 2018, 117,008 chlamydia cases were reported that corresponds to 363.2 cases per 100,000 population. During the same timeframe, around 76.1% of chlamydia cases were reported among people aged lower than 30 years of age. The prevalence rates of Gonorrhea have almost doubled in the past few years. Moreover, the incidence rates of infectious syphilis have more than tripled and witnessed the highest surge with over 259.5% increase. Moreover, favourable government policies are further anticipated to promote the industry growth. For instance, the Canadian government agencies support the access to contraceptives, as an integral component of sexual and reproductive health in the country that is set to propel the use of contraceptives. Hence, the rising prevalence of STIs and favorable initiatives adopted by the government are fostering the contraceptives market growth in Canada.

The North American contraceptive market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2028, for the following segments:

North America Market, By Product

• Drugs
  • Oral Contraceptive Pills
  • Injectable Contraceptives
  • Topical Contraceptives
• Devices
  • Condoms
    • Male
    • Female
  • Diaphragms
  • Contraceptive Sponges
  • Vaginal Rings
  • Sub-dermal Implants
  • Intra-uterine Devices
    • Copper IUD
    • Hormonal IUD
• Others

The above information has been provided for the following countries:

• North America
  • U.S.
  • Canada